These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 21688264

  • 1. Glucocorticoid alternative effects on proliferating and differentiated mammary epithelium are associated to opposite regulation of cell-cycle inhibitor expression.
    Hoijman E, Rocha-Viegas L, Kalko SG, Rubinstein N, Morales-Ruiz M, Joffé EB, Kordon EC, Pecci A.
    J Cell Physiol; 2012 Apr; 227(4):1721-30. PubMed ID: 21688264
    [Abstract] [Full Text] [Related]

  • 2. Expression of CSF-I and CSF-I receptor by normal lactating mammary epithelial cells.
    Sapi E, Flick MB, Rodov S, Carter D, Kacinski BM.
    J Soc Gynecol Investig; 1998 Apr; 5(2):94-101. PubMed ID: 9509388
    [Abstract] [Full Text] [Related]

  • 3. Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis.
    Sgambato A, Di Salvatore MA, De Paola B, Rettino A, Faraglia B, Boninsegna A, Graziani C, Camerini A, Proietti G, Cittadini A.
    J Cell Physiol; 2006 May; 207(2):520-9. PubMed ID: 16447256
    [Abstract] [Full Text] [Related]

  • 4. Vanadate disrupts mammary gland development in whole organ culture.
    Gallo-Hendrikx E, Murray SA, Vonderhaar BK, Xiao ZX.
    Dev Dyn; 2001 Nov; 222(3):354-67. PubMed ID: 11747071
    [Abstract] [Full Text] [Related]

  • 5. Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.
    Loehberg CR, Thompson T, Kastan MB, Maclean KH, Edwards DG, Kittrell FS, Medina D, Conneely OM, O'Malley BW.
    Cancer Res; 2007 Dec 15; 67(24):12026-33. PubMed ID: 18089834
    [Abstract] [Full Text] [Related]

  • 6. Control of Atm-/- thymic lymphoma cell proliferation in vitro and in vivo by dexamethasone.
    Kuang X, Yan M, Liu N, Scofield VL, Qiang W, Cahill J, Lynn WS, Wong PK.
    Cancer Chemother Pharmacol; 2005 Mar 15; 55(3):203-12. PubMed ID: 15570424
    [Abstract] [Full Text] [Related]

  • 7. Developmentally regulated inhibition of cell cycle progression by glucocorticoids through repression of cyclin A transcription in primary osteoblast cultures.
    Gabet Y, Noh T, Lee C, Frenkel B.
    J Cell Physiol; 2011 Apr 15; 226(4):991-8. PubMed ID: 20857405
    [Abstract] [Full Text] [Related]

  • 8. Glucocorticoid-induced impairment of mammary gland involution is associated with STAT5 and STAT3 signaling modulation.
    Bertucci PY, Quaglino A, Pozzi AG, Kordon EC, Pecci A.
    Endocrinology; 2010 Dec 15; 151(12):5730-40. PubMed ID: 20881248
    [Abstract] [Full Text] [Related]

  • 9. Cell cycle regulation during mouse olfactory neurogenesis.
    Legrier ME, Ducray A, Propper A, Chao M, Kastner A.
    Cell Growth Differ; 2001 Dec 15; 12(12):591-601. PubMed ID: 11751454
    [Abstract] [Full Text] [Related]

  • 10. Regulation of type II deiodinase expression by EGF and glucocorticoid in HC11 mouse mammary epithelium.
    Song S, Oka T.
    Am J Physiol Endocrinol Metab; 2003 Jun 15; 284(6):E1119-24. PubMed ID: 12582014
    [Abstract] [Full Text] [Related]

  • 11. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland.
    Ip C, Thompson HJ, Ganther HE.
    Cancer Epidemiol Biomarkers Prev; 2000 Jan 15; 9(1):49-54. PubMed ID: 10667463
    [Abstract] [Full Text] [Related]

  • 12. Parous mammary glands exhibit distinct alterations in gene expression and proliferation responsiveness to carcinogenic stimuli in Lewis rats.
    Uehara N, Unami A, Kiyozuka Y, Shikata N, Oishi Y, Tsubura A.
    Oncol Rep; 2006 Apr 15; 15(4):903-11. PubMed ID: 16525678
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis in normal and neoplastic mammary gland development.
    Strange R, Metcalfe T, Thackray L, Dang M.
    Microsc Res Tech; 2001 Jan 15; 52(2):171-81. PubMed ID: 11169865
    [Abstract] [Full Text] [Related]

  • 14. Induction of bcl-xL expression in mammary epithelial cells is glucocorticoid-dependent but not signal transducer and activator of transcription 5-dependent.
    Schorr K, Furth PA.
    Cancer Res; 2000 Nov 01; 60(21):5950-3. PubMed ID: 11085510
    [Abstract] [Full Text] [Related]

  • 15. Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.
    Bowen TJ, Yakushiji H, Montagna C, Jain S, Ried T, Wynshaw-Boris A.
    Cancer Res; 2005 Oct 01; 65(19):8736-46. PubMed ID: 16204043
    [Abstract] [Full Text] [Related]

  • 16. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
    Goddio MV, Gattelli A, Slomiansky V, Lacunza E, Gingerich T, Tocci JM, Facchinetti MM, Curino AC, LaMarre J, Abba MC, Kordon EC.
    Breast Cancer Res Treat; 2012 Oct 01; 135(3):749-58. PubMed ID: 22968621
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor binding protein (IGFBP)-5 is upregulated during both differentiation and apoptosis in primary cultures of mouse mammary epithelial cells.
    Lochrie JD, Phillips K, Tonner E, Flint DJ, Allan GJ, Price NC, Beattie J.
    J Cell Physiol; 2006 May 01; 207(2):471-9. PubMed ID: 16419030
    [Abstract] [Full Text] [Related]

  • 18. Protein 4.1B expression is induced in mammary epithelial cells during pregnancy and regulates their proliferation.
    Kuns R, Kissil JL, Newsham IF, Jacks T, Gutmann DH, Sherman LS.
    Oncogene; 2005 Sep 29; 24(43):6502-15. PubMed ID: 16007173
    [Abstract] [Full Text] [Related]

  • 19. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
    Iavnilovitch E, Groner B, Barash I.
    Mol Cancer Res; 2002 Nov 29; 1(1):32-47. PubMed ID: 12496367
    [Abstract] [Full Text] [Related]

  • 20. Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase-dependent pathway.
    De Santis ML, Kannan S, Smith GH, Seno M, Bianco C, Kim N, Martinez-Lacaci I, Wallace-Jones B, Salomon DS.
    Cell Growth Differ; 1997 Dec 29; 8(12):1257-66. PubMed ID: 9419414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.